Blood cadmium and depressive symptoms in young adults (aged 20-39 years)

Psychological Medicine

Volumn 45, Issue 4, 2015, Pages 807-815

  Scinicariello, F ^a,b   Buser, M C ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Blood cadmium; blood lead; cigarette smoking; depressive symptoms; NHANES

Indexed keywords

CADMIUM;

ADULT; ADVERSE EFFECTS; BLOOD; DEPRESSION; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; SMOKING; UNITED STATES; YOUNG ADULT;

ADULT; CADMIUM; DEPRESSION; FEMALE; HUMANS; MALE; SMOKING; UNITED STATES; YOUNG ADULT;

EID: 84927695048     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714001883     Document Type: Article

References (44)

1. Ali M, Mathur N, Chandra S (1990). Effect of chronic cadmium exposure on locomotor behaviour of rats. Indian Journal of Experimental Biology 28, 653-656.
2. ATSDR (2012). Toxicological Profile for Cadmium. US Agency for Toxic Substances and Disease Registry: Atlanta, GA.
3. Aubin HJ, Rollema H, Svensson TH, Winterer G (2012). Smoking, quitting, and psychiatric disease: a review. Neuroscience and Biobehavioral Reviews 36, 271-284.
4. Bandiera FC, Arheart KL, Caban-Martinez AJ, Fleming LE, McCollister K, Dietz NA, Leblanc WG, Davila EP, Lewis JE, Serdar B, Lee DJ (2010). Secondhand smoke exposure and depressive symptoms. Psychosomatic Medicine 72, 68-72.
5. Barański B (1984). Behavioral alterations in offspring of female rats repeatedly exposed to cadmium oxide by inhalation. Toxicology Letters 22, 53-61.
6. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J (2009). Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. American Journal of Epidemiology 169, 236-248.
7. Boden JM, Fergusson DM, Horwood LJ (2010). Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. British Journal of Psychiatry 196, 440-446.
8. Bot M, Vink JM, Willemsen G, Smith JH, Neuteboom J, Kluft C, Boomsma DI, Penninx BW (2013). Exposure to secondhand smoke and depression and anxiety: a report from two studies in the Netherlands. Journal of Psychosomatic Research 75, 431-436.
9. Bouchard MF, Bellinger DC, Weuve J, Matthews-Bellinger J, Gilman SE, Wright RO, Schwartz J, Weisskopf MG (2009). Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Archives of General Psychiatry 66, 1313-1319.
10. Capel ID, Pinnock MH, Dorrell H, Williams DC, Grant E (1981). Comparison of concentrations of some trace, bulk, and toxic metals in the hair of normal and dyslexic children. Clinical Chemistry 27, 879-881.
11. Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, Hotopf M, Stewart R (2011). Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE 6, e19590.
12. Ciesielski T, Weuve J, Bellinger DC, Schwartz J, Lanphear B, Wright RO (2012). Cadmium exposure and neurodevelopmental outcomes in US children. Environmental Health Perspectives 120, 758-763.
13. Cohen-Woods S, Craig IW, McGuffin P (2013). The current state of play on the molecular genetics of depression. Psychological Medicine 43, 673-687.
14. Crone MR, Reijneveld SA (2007). The association of behavioural and emotional problems with tobacco use in adolescence. Addictive Behaviors 32, 1692-1698.
15. Golub NI, Winters PC, van Wijngaarden E (2010). A population-based study of blood lead levels in relation to depression in the United States. International Archives of Occupational and Environmental Health 83, 771-777.
16. Gonçalves JF, Fiorenza AM, Spanevello RM, Mazzanti CM, Bochi GV, Antes FG, Stefanello N, Rubin MA, Dressler VL, Morsch VM, Schetinger MR (2010). N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium. Chemico-Biological Interactions 186, 53-60.
17. Gonçalves JF, Nicoloso FT, da Costa P, Farias JG, Carvalho FB, da Rosa MM, Gutierres JM, Abdalla FH, Pereira JS, Dias GR, Barbosa NB, Dressler VL, Rubin MA, Morsch VM, Schetinger MR (2012). Behavior and brain enzymatic changes after long-term intoxication with cadmium salt or contaminated potatoes. Food and Chemical Toxicology 50, 3709-3718.
18. Hart RP, Rose CS, Hamer RM (1989). Neuropsychological effects of occupational exposure to cadmium. Journal of Clinical and Experimental Neuropsychology 11, 933-943.
19. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998). Health effects of cadmium exposure - a review of the literature and a risk estimate. Scandinavian Journal of Work, Environment and Health 24 (Suppl. 1), 1-51.
20. Jarup L, Rogenfelt A, Elinder CG, Nogawa K, Kjellstrom T (1983). Biological half-time of cadmium in the blood of workers after cessation of exposure. Scandinavian Journal of Work, Environment and Health 9, 327-331.
21. Johnson JL, Moffat BM, Malchy LA (2010). In the shadow of a new smoke free policy: a discourse analysis of health care providers' engagement in tobacco control in community mental health. International Journal of Mental Health Systems 4, 23.
22. Kessler RC, Bromet EJ (2013). The epidemiology of depression across cultures. Annual Review of Public Health 34, 119-138.
23. Kocalevent RD, Hinz A, Brahler E (2013). Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. General Hospital Psychiatry 35, 551-555.
24. Kroenke K, Spitzer RL, Williams JB (2001). The PHQ-9. Journal of General Internal Medicine 16, 606-613.
25. Lafuente A, Gonzalez-Carracedo A, Romero A, Esquifino A (2003). Effect of cadmium on 24-h variations in hypothalamic dopamine and serotonin metabolism in adult male rats. Experimental Brain Research 149, 200-206.
26. Lafuente A, Márquez N, Perez-Lorenzo M, Pazo D, Esquifino AI (2001). Cadmium effects on hypothalamic-pituitary-testicular axis in male rats. Experimental Biology and Medicine 226, 605-611.
27. Lam E, Kvaavik E, Hamer M, Batty GD (2013). Association of secondhand smoke exposure with mental health in men and women: cross-sectional and prospective analyses using the U.K. Health and Lifestyle Survey. European Psychiatry: Journal of the Association of European Psychiatrists 28, 276-281.
28. Lanni C, Govoni S, Lucchelli A, Boselli C (2009). Depression and antidepressants: molecular and cellular aspects. Cellular and Molecular Life Sciences 66, 2985-3008.
29. Leret ML, Millan JA, Antonio MT (2003). Perinatal exposure to lead and cadmium affects anxiety-like behaviour. Toxicology 186, 125-130.
30. Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG (1998). Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychology 17, 56-62.
31. Martin A, Rief W, Klaiberg A, Braehler E (2006). Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. General Hospital Psychiatry 28, 71-77.
32. Mendez-Armenta M, Rios C (2007). Cadmium neurotoxicity. Environmental Toxicology and Pharmacology 23, 350-358.
33. Nakata A, Takahashi M, Ikeda T, Hojou M, Nigam JA, Swanson NG (2008). Active and passive smoking and depression among Japanese workers. Preventive Medicine 46, 451-456.
34. NCHS (2008a). National Health and Nutrition Examination Survey Home Page. Centers for Disease Control and Prevention, National Center for Health Statistics: Atlanta, GA (www.cdc.gov/nchs/nhanes.htm). Accessed April 2014.
35. NCHS (2008b). Continuous National Health and Nutrition Examination Survey (NHANES) Web Tutorial.
36. Constructing Weights for Combined NHANES Survey Cycles. Centers for Disease Control and Prevention, National Center for Health Statistics: Atlanta, GA (www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/Weighting/intro.htm). Accessed April 2014.
37. Pomerleau CS, Pomerleau OF (1992). Euphoriant effects of nicotine in smokers. Psychopharmacology 108, 460-465.
38. Rodgman A, Perfetti TA (2008). The Chemical Components of Tobacco and Tobacco Smoke. CRC Press: Boca Raton, CA.
39. Stanley PC, Wakwe VC (2002). Toxic trace metals in the mentally ill patients. Nigerian Postgraduate Medical Journal 9, 199-204.
40. Stellern J, Marlowe M, Cossairt A, Errera J (1983). Low lead and cadmium levels and childhood visual-perception development. Perceptual and Motor Skills 56, 539-544.
41. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D (2003). Cost of lost productive work time among US workers with depression. Journal of the American Medical Association 289, 3135-3144.
42. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P (2014). Change in mental health after smoking cessation: systematic review and meta-analysis. British Medical Journal 348, g1151.
43. Viaene M, Masschelein R, Leenders J, De Groof M, Swerts L, Roels H (2000). Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study. Occupational and Environmental Medicine 57, 19-27.
44. Weaver TL, Etzel JC (2003). Smoking patterns, symptoms of PTSD and depression: preliminary findings from a sample of severely battered women. Addictive Behaviors 28, 1665-1679.